Acumen Pharmaceuticals Inc (ABOS)

Finanzdaten der Acumen Pharmaceuticals Inc-Aktie (ABOS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	20.71%25.81	32.56	21.15	25.20	26.51
Research and Development	24.08%21.11	27.81	16.48	20.53	21.97
Operating Income/Loss	20.71%-25.81	-32.56	-21.15	-25.20	-26.51
Nonoperating Income/Loss	374.07%0.44	-0.16	0.41	0.06	0.06
	22.46%-25.37	-32.72	-20.74	-25.14	-26.45
Attributable To Parent	22.46%-25.37	-32.72	-20.74	-25.14	-26.45
Basic Average Shares	0.10%72.32	72.25	63.22	-	60.57
Diluted Average Shares	0.10%72.32	72.25	63.22	-	60.57
Basic Earnings Per Share	22.22%-0.35	-0.45	-0.33	-	-0.44
Diluted Earnings Per Share	22.22%-0.35	-0.45	-0.33	-	-0.44